NAFLD predominantly manifests in patients with obesity, insulin resistance, and dyslipidemia [3], although genetic factors, such as Patatin-like phospholipase domain-containing protein 3 (PNPLA3), play a role [2]. Here, PNPLA3 is linked to obesity due to melanocortin 4 receptor deficiency.